PQA
- Product code
- PQA
- Device name
- Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.3975
- Medical specialty
- Microbiology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 4
- Summaries archived here
- 3 (direct download)
- 510(k) clearances (all years, FDA)
- 12 (all years; only the last 3 years are listed here)
FDA classification definition
A vaginitis and bacterial vaginosis nucleic acid detection system is a qualitative in vitro diagnostic device for the direct detection of nucleic acid sequences from microorganisms associated with vaginitis or bacterial vaginosis. The device is indicated for individuals with signs and symptoms of vaginitis or bacterial vaginosis and aids in the diagnosis of these vaginal infections.
510(k) clearances, last 3 years (4)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K260021 | 2026-07-16 | Roche Molecular Systems, Inc. | cobas® BV/CV | |
| K243725 | 2024-12-19 | Becton, Dickinson and Company | BD Vaginal Panel | FDA |
| K243345 | 2024-11-25 | Hologic, Inc. | Aptima BV Assay; Aptima CV/TV Assay | |
| K231381 | 2023-10-19 | Cepheid | Xpert Xpress MVP; GeneXpert Xpress System |
Official FDA classification page: PQA
Classification and pathway per current FDA publications. Data from openFDA (CC0).